Simon Bond
Simon Bond
Cambridge Clinical Trials Unit, MRC Biostatistics Unit
Verified email at
Cited by
Cited by
Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial
K Anagnostou, S Islam, Y King, L Foley, L Pasea, S Bond, C Palmer, ...
The Lancet 383 (9925), 1297-1304, 2014
Prospective validation of the pulmonary embolism severity index
J Donzé, G Le Gal, MJ Fine, PM Roy, O Sanchez, F Verschuren, J Cornuz, ...
Thrombosis and haemostasis 100 (05), 943-948, 2008
Combined prolonged-release oxycodone and naloxone improves bowel function in patients receiving opioids for moderate-to-severe non-malignant chronic pain: a randomised …
O Löwenstein, P Leyendecker, M Hopp, U Schutter, PD Rogers, R Uhl, ...
Expert opinion on pharmacotherapy 10 (4), 531-543, 2009
Systematic overview of preoperative (neoadjuvant) chemoradiotherapy trials in oesophageal cancer: evidence of a radiation and chemotherapy dose response
JI Geh, SJ Bond, SM Bentzen, R Glynne-Jones
Radiotherapy and oncology 78 (3), 236-244, 2006
Radiotherapy-related early morbidity in head and neck cancer: quantitative clinical radiobiology as deduced from the CHART trial
SM Bentzen, MI Saunders, S Dische, SJ Bond
Radiotherapy and Oncology 60 (2), 123-135, 2001
Predictors for radiological damage in psoriatic arthritis: results from a single centre
SJ Bond, VT Farewell, CT Schentag, DD Gladman
Annals of the rheumatic diseases 66 (3), 370-376, 2007
Trial of Dexamethasone for Chronic Subdural Hematoma
PJ Hutchinson, E Edlmann, D Bulters, A Zolnourian, P Holton, N Suttner, ...
New England Journal of Medicine, 2020
Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial
JA Todd, M Evangelou, AJ Cutler, ML Pekalski, NM Walker, HE Stevens, ...
PLoS medicine 13 (10), e1002139, 2016
Rituximab as therapy to induce remission after relapse in ANCA-associated vasculitis
RM Smith, RB Jones, U Specks, S Bond, M Nodale, R Aljayyousi, ...
Annals of the rheumatic diseases 79 (9), 1243-1249, 2020
Selection of active drugs for ovarian cancer based on CA-125 and standard response rates in phase II trials
GJS Rustin, AE Nelstrop, SM Bentzen, SJ Bond, P McClean
Journal of clinical oncology 18 (8), 1733-1739, 2000
Low absolute bioavailability of oral naloxone in healthy subjects.
K Smith, M Hopp, G Mundin, S Bond, P Bailey, J Woodward, D Bell
International journal of clinical pharmacology and therapeutics 50 (5), 360-367, 2012
ACE inhibitors and statins in adolescents with type 1 diabetes
ML Marcovecchio, ST Chiesa, S Bond, D Daneman, S Dawson, ...
New England Journal of Medicine 377 (18), 1733-1745, 2017
National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993
AS Denton, SJ Bond, S Matthews, SM Bentzen, EJ Maher, UKLGO Group
Clinical Oncology 12 (6), 347-353, 2000
Ultrasound elastography as an adjuvant to conventional ultrasound in the preoperative assessment of axillary lymph nodes in suspected breast cancer: a pilot study
K Taylor, S O’Keeffe, PD Britton, MG Wallis, GM Treece, J Housden, ...
Clinical radiology 66 (11), 1064-1071, 2011
Low-dose interleukin-2 in patients with stable ischaemic heart disease and acute coronary syndromes (LILACS): protocol and study rationale for a randomised, double-blind …
TX Zhao, M Kostapanos, C Griffiths, EL Arbon, A Hubsch, F Kaloyirou, ...
BMJ open 8 (9), e022452, 2018
Effect of sleep deprivation and exercise on reaction threshold in adults with peanut allergy: a randomized controlled study
S Dua, M Ruiz-Garcia, S Bond, SR Durham, I Kimber, C Mills, G Roberts, ...
Journal of Allergy and Clinical Immunology 144 (6), 1584-1594. e2, 2019
The Australian Workplace Barometer: Report on psychosocial safety climate and worker health in Australia
M Dollard, T Bailey, S McLinton, P Richards, W McTernan, A Taylor, ...
Safe Work Australia, 2012
How to design a dose-finding study using the continual reassessment method
GM Wheeler, AP Mander, A Bedding, K Brock, V Cornelius, AP Grieve, ...
BMC medical research methodology 19, 1-15, 2019
Chronic dipeptidyl peptidase-4 inhibition with sitagliptin is associated with sustained protection against ischemic left ventricular dysfunction in a pilot study of patients …
LM McCormick, AC Kydd, PA Read, LS Ring, SJ Bond, SP Hoole, ...
Circulation: Cardiovascular Imaging 7 (2), 274-281, 2014
Naloxone as part of a prolonged release oxycodone/naloxone combination reduces oxycodone-induced slowing of gastrointestinal transit in healthy volunteers
K Smith, M Hopp, G Mundin, S Bond, P Bailey, J Woodward, ...
Expert opinion on investigational drugs 20 (4), 427-439, 2011
The system can't perform the operation now. Try again later.
Articles 1–20